TTS Pharma  
About Us
TTS Pharma was formed in late 2012 to acquire Transdermal Technology & Systems (TTS) Limited as part of a strategic investment and corporate restructuring to prepare it for growth and to enable the group to undertake activities in both Europe and Asia. TTS Limited is a wholly owned subsidiary of TTS Pharma and undertakes its operating activities primarily in UK.

TTS Pharma is privately owned and controlled, and is supported by Spark Impact and the European Investment Bank.

TTSPharma is a proud member of:

Contact Us

Mark R Tucker
CEO & Founder
T: +44 (0)787 521 0959
SKYPE: mrtucker

Registered Office:
Liverpool Science Park
131 Mount Pleasant
L3 5TF

Website Builder